Physician Q&A: How to Boost Confidence in Biosimilars
How Independent Oncology Practices can Increase Referrals
Four tips for generating more referrals from hospital-affiliated physicians.
How to Navigate Cell and Gene Therapy Reimbursement: Part Two
An executive Q&A on the role of data and the future of innovative reimbursement modeling for cell and gene therapies.
How to Navigate Cell and Gene Therapy Reimbursement: Part One
An executive Q&A on challenges and opportunities related to reimbursement, coding and coverage for cell and gene therapies.
Rethink: Channel Strategy for Oral Oncolytics
How manufacturers can benefit from provider-led care coordination to improve patient outcomes.
Caring for the Whole Patient
The growing trend toward value-based payment models and ongoing demand for clinical outcomes creates a need for better coordination of care. What challenges does this create for health system specialty pharmacies and what opportunities does this present for demonstrating value?
How Successful Oncology Practices are Continuing to Prosper Through Innovation
An industry expert explains how oncology practices are thriving by embracing innovation.
The Growth of Biosimilars in the Oncology Pipeline
What should biosimilar manufacturers focus on for commercialization success?
Leveraging Data Analytics for the Value-based Care Transition
How community oncology practices can unlock the power of data for successful value-based care.
Five Ways to Stop Practice Profit Leaks
Five ways that oncology practices can optimize their operations and avoid financial strain.
Ambulatory Care and the Health System Pharmacy
A look at the trends and growth of cancer care alongside the critical considerations health systems need to weigh as they look to deliver the highest quality and most cost effective care in oncology.
Cancer Care at a Crossroads
A look at the trends and growth of cancer care alongside the critical considerations health systems need to weigh as they look to deliver the highest quality.
The Metamorphosis of a Community Oncology Practice
New England Cancer Specialists demonstrates why staying the same simply isn't an option when it comes to cancer care.
Five Oncology Trends Impacting the Patient Experience
New challenges to oncology product access, optimized clinical outcomes and commercial success, with strategic recommendations for how pharmaceutical manufacturers can support prescribers and patients through the continuum of cancer care.
Adherence to Oral Oncolytics Requires a Clinically Integrated Approach to Specialty Pharmacy
How greater collaboration between oncologists and pharmacists can drive patient-centered solutions to improve adherence.